Logo Image
News|Articles|December 29, 2023

Top 3 Most Read CRO/Sponsor Feature Articles of 2023

Authors highlighted outsourcing and the impact of the COVID-19 pandemic in these CRO/sponsor articles from 2023.

Below is a list of the most read CRO/sponsor articles featured on Applied Clinical Trials in 2023.

1. COVID-19 Pandemic Exemplifies the Benefits of CROs

Clinical research is necessary for the development of new health products. The evaluation of the safety and efficacy of new drugs or devices in patients is already governed by numerous regulations. Furthermore, speed requirements and competition between the various pharmaceutical and biotech companies are also factors in the dynamics of the industry. All these aspects intensified during the outbreak of the COVID-19 pandemic which was an opportunity to exemplify the unique role that CROs play in clinical research due to their expertise and ability to rapidly adapt and respond to a changing environment.

Read the full article here.

2. Outsourcing Model Usage and its Relationship to Clinical Trial Performance

Tufts Center for the Study of Drug Development (CSDD) and ICON plc proposed a new framework to differentiate sourcing models based on type of contract services. Rather than using traditional definitions this novel approach uses the CRO’s infrastructure and processes for clinical trial conduct resulting in mixed models and combinations of sourcing models. The development of this classification is based on the following factors: outsourcing orientation, infrastructure support, and accountability or contracting structure.

Read the full article here.

3. Harmonizing Outsourcing to Keep Clinical Trials on Track

In the past decade, the clinical research industry has experienced a proliferation of new outsourcing models and operational strategies in which CROs and sponsors are working in more integrated ways. Against the background of the increasingly complex clinical research landscape, we have seen a rise in strategic partnerships and partnership-driven approaches to outsourcing as a way to navigate that complexity and more effectively deliver clinical trials.

Now more than ever, developing a shared partnership culture is important to support the more complex strategic objectives and operative functions that keep clinical trials humming.

Read the full article here.

Related to this article

View more
© photon_photo - © photon_photo - stock.adobe.com
Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
Read more
What Expanding AI Ecosystems Mean for Sponsor Complexity and Oversight
What Expanding AI Ecosystems Mean for Sponsor Complexity and Oversight
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, argues that CROs must act as orchestrators rather than aggregators—and that the real test of any AI ecosystem is whether it reduces sponsor coordination burden or just hands it back to them.
Read more
© putilov_denis - © putilov_denis - stock.adobe.com
Real-Time Clinical Trials Depend on a Scalable EHR-to-EDC Connection
Real-time clinical trials require standardized digital data capture at the point of care through scaled eSource-EDC-EHR integration, but progress stalls because competing standards lack regulatory enforcement and one-off system integrations cannot scale beyond single studies without industry-wide alignment and legal clarity on data ownership.
Read more
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
Read more